MXCT (STOCKS)
MaxCyte, Inc. Common Stock
$1.400000
+0.130000 (+10.24%)
Prev close: $1.270000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Maher Masoud
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $176.73M
- Employees
- 114
- P/E (TTM)
- -3.46
- P/B (TTM)
- 0.81
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $32.29M |
| Benefits Costs and Expenses | $71.41M |
| Cost Of Revenue | $6.29M |
| Costs And Expenses | $71.41M |
| Gross Profit | $25.99M |
| Operating Expenses | $71.78M |
| Depreciation and Amortization | $4.18M |
| Research and Development | $18.78M |
| Other Operating Expenses | $48.82M |
| Operating Income/Loss | -$45.79M |
| Income/Loss From Continuing Operations After Tax | -$39.12M |
| Income/Loss From Continuing Operations Before Tax | -$39.12M |
| Net Income/Loss | -$39.12M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$39.12M |
| Net Income/Loss Available To Common Stockholders, Basic | -$39.12M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.37 |
| Diluted Earnings Per Share | -$0.37 |
| Basic Average Shares | 319,994,764 |
| Diluted Average Shares | 319,994,764 |
| Assets | $194.47M |
| Current Assets | $122.94M |
| Inventory | $7.63M |
| Other Current Assets | $115.31M |
| Noncurrent Assets | $71.54M |
| Fixed Assets | $16.64M |
| Intangible Assets | $783.00K |
| Other Non-current Assets | $54.12M |
| Liabilities | $26.59M |
| Current Liabilities | $10.21M |
| Accounts Payable | $1.20M |
| Other Current Liabilities | $9.02M |
| Noncurrent Liabilities | $16.38M |
| Equity | $167.89M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $167.89M |
| Liabilities And Equity | $194.47M |
| Net Cash Flow From Operating Activities | -$28.17M |
| Net Cash Flow From Operating Activities, Continuing | -$28.17M |
| Net Cash Flow From Investing Activities | $19.06M |
| Net Cash Flow From Investing Activities, Continuing | $19.06M |
| Net Cash Flow From Financing Activities | $278.00K |
| Net Cash Flow From Financing Activities, Continuing | $278.00K |
| Net Cash Flow | -$8.83M |
| Net Cash Flow, Continuing | -$8.83M |
| Comprehensive Income/Loss | -$39.12M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$39.12M |
| Other Comprehensive Income/Loss | $0.00 |